Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 20 of 24 found articles
 
 
  Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial
 
 
Title: Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial
Author: Hamer, Melinda J
Houser, Katherine V
Hofstetter, Amelia R
Ortega-Villa, Ana M
Lee, Christine
Preston, Anne
Augustine, Brooke
Andrews, Charla
Yamshchikov, Galina V
Hickman, Somia
Schech, Steven
Hutter, Jack N
Scott, Paul T
Waterman, Paige E
Amare, Mihret F
Kioko, Victoria
Storme, Casey
Modjarrad, Kayvon
McCauley, Melanie D
Robb, Merlin L
Gaudinski, Martin R
Gordon, Ingelise J
Holman, LaSonji A
Widge, Alicia T
Strom, Larisa
Happe, Myra
Cox, Josephine H
Vazquez, Sandra
Stanley, Daphne A
Murray, Tamar
Dulan, Caitlyn N M
Hunegnaw, Ruth
Narpala, Sandeep R
Swanson II, Phillip A
Basappa, Manjula
Thillainathan, Jagada
Padilla, Marcelino
Flach, Britta
O’Connell, Sarah
Trofymenko, Olga
Morgan, Patricia
Coates, Emily E
Gall, Jason G
McDermott, Adrian B
Koup, Richard A
Mascola, John R
Ploquin, Aurélie
Sullivan, Nancy J
Ake, Julie A
Ledgerwood, Julie E
Appeared in: Lancet
Paging: Volume 401 () nr. 10373 pages 294-302
Year: 2023
Contents:
Publisher: Elsevier Ltd
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 20 of 24 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands